Curaleaf (OTCMKTS:CURLF) Shares Gap Down – Here’s Why

Curaleaf Holdings, Inc. (OTCMKTS:CURLF) gapped down prior to trading on Wednesday . The stock had previously closed at $9.96, but opened at $9.28. Curaleaf shares last traded at $9.8868, with a volume of 5,224 shares.

Wall Street Analysts Forecast Growth

Several analysts have recently commented on CURLF shares. Zacks Research raised shares of Curaleaf from a “hold” rating to a “strong-buy” rating in a research note on Tuesday, July 14th. Citigroup restated a “buy” rating on shares of Curaleaf in a research report on Thursday, August 6th. Three analysts have rated the stock with a Strong Buy rating and two have assigned a Buy rating to the company’s stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Strong Buy”.

Curaleaf Stock Performance

The stock has a market capitalization of $2.42 billion, a price-to-earnings ratio of -79.60 and a beta of 1.57. The company has a debt-to-equity ratio of 1.06, a current ratio of 1.52 and a quick ratio of 0.73. The stock has a 50-day moving average of $9.08 and a 200 day moving average of $8.09.

Curaleaf (OTCMKTS:CURLF) last released its earnings results on Wednesday, August 5th. The company reported $0.05 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.20) by $0.25. The company had revenue of $340.10 million for the quarter, compared to the consensus estimate of $332.00 million. Curaleaf had a negative net margin of 2.62% and a negative return on equity of 0.88%. On average, analysts expect that Curaleaf Holdings, Inc. will post 0.01 EPS for the current year.

About Curaleaf

Curaleaf Holdings, Inc is a leading American cannabis company engaged in the cultivation, processing and distribution of both medical and adult-use cannabis products. Headquartered in Wakefield, Massachusetts, Curaleaf operates cultivation facilities, processing centers and retail dispensaries across multiple U.S. jurisdictions. The company’s vertically integrated model allows it to manage the entirety of its supply chain, from seed to sale, ensuring consistent quality and compliance with stringent regulatory requirements.

Curaleaf’s product portfolio spans a wide range of formats, including premium flower, vaporizer cartridges, edibles, tinctures, topicals and concentrates.